Provider
QP95-24 Commercial Pharmacy Benefit Exclusion for lanreotide, Ultomiris® and Visudyne®
Program effective Date: Dec 23, 2024
Program effective Date: Dec 23, 2024
This notice describes how medical information about you may be used and disclosed, and how you can get access to this information. Please review this notice carefully.
Program effective Date: Dec 11, 2024
Program effective Date: Dec 11, 2024